302 related articles for article (PubMed ID: 12743575)
41. Safe full-dose one-step nabumetone challenge in patients with nonsteroidal anti-inflammatory drug hypersensitivity.
Confino-Cohen R; Goldberg A
Allergy Asthma Proc; 2003; 24(4):281-4. PubMed ID: 12974196
[TBL] [Abstract][Full Text] [Related]
42. Safety of rofecoxib in subjects with a history of adverse cutaneous reactions to aspirin and/or non-steroidal anti-inflammatory drugs.
Pacor ML; Di Lorenzo G; Biasi D; Barbagallo M; Corrocher R
Clin Exp Allergy; 2002 Mar; 32(3):397-400. PubMed ID: 11940070
[TBL] [Abstract][Full Text] [Related]
43. The Frequency of Nonsteroidal Anti-Inflammatory Drug Hypersensitivity in Children with Asthma.
Guvenir H; Dibek Misirlioglu E; Capanoglu M; Buyuktiryaki B; Onay ZR; Ginis T; Toyran M; Civelek E; Kocabas CN
Int Arch Allergy Immunol; 2018; 176(1):26-32. PubMed ID: 29590651
[TBL] [Abstract][Full Text] [Related]
44. Benzydamine: an alternative nonsteroidal anti-inflammatory drug in patients with nimesulide-induced urticaria.
Nettis E; Di Paola R; Napoli G; Ferrannini A; Tursi A
Allergy; 2002 May; 57(5):442-5. PubMed ID: 11972485
[TBL] [Abstract][Full Text] [Related]
45. Sera from patients with multiple drug allergy syndrome contain circulating histamine-releasing factors.
Asero R; Tedeschi A; Lorini M; Caldironi G; Barocci F
Int Arch Allergy Immunol; 2003 Jul; 131(3):195-200. PubMed ID: 12876410
[TBL] [Abstract][Full Text] [Related]
46. Evaluation and Updated Classification of Acute Hypersensitivity Reactions to Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): NSAID-Exacerbated or -Induced Food Allergy.
Romano A; Gaeta F; Caruso C; Fiocchi A; Valluzzi RL
J Allergy Clin Immunol Pract; 2023 Jun; 11(6):1843-1853.e1. PubMed ID: 36997117
[TBL] [Abstract][Full Text] [Related]
47. Tolerability of nimesulide and paracetamol in patients with NSAID-induced urticaria/angioedema.
Nettis E; Marcandrea M; Ferrannini A; Tursi A
Immunopharmacol Immunotoxicol; 2001 Aug; 23(3):343-54. PubMed ID: 11694026
[TBL] [Abstract][Full Text] [Related]
48. Etoricoxib: a safe alternative for NSAID intolerance in Asian patients.
Llanora GV; Loo EX; Gerez IF; Cheng YK; Shek LP
Asian Pac J Allergy Immunol; 2013 Dec; 31(4):330-3. PubMed ID: 24383977
[TBL] [Abstract][Full Text] [Related]
49. An Overview of Nonsteroidal Antiinflammatory Drug Reactions.
Walters KM; Woessner KM
Immunol Allergy Clin North Am; 2016 Nov; 36(4):625-641. PubMed ID: 27712759
[TBL] [Abstract][Full Text] [Related]
50. Evaluating the negative predictive value of provocation tests with nonsteroidal anti-inflammatory drugs.
Defrance C; Bousquet PJ; Demoly P
Allergy; 2011 Nov; 66(11):1410-4. PubMed ID: 21722141
[TBL] [Abstract][Full Text] [Related]
51. Tolerability of three selective cyclo-oxygenase-2 inhibitors, meloxicam, celecoxib and rofecoxib in NSAID-sensitive patients.
Senna G; Bilò MB; Antonicelli L; Schiappoli M; Crivellaro MA; Bonadonna P; Dama AR
Eur Ann Allergy Clin Immunol; 2004 Jun; 36(6):215-8. PubMed ID: 15329003
[TBL] [Abstract][Full Text] [Related]
52. Immediate Reactions to More Than 1 NSAID Must Not Be Considered Cross-Hypersensitivity Unless Tolerance to ASA Is Verified.
Pérez-Alzate D; Cornejo-García JA; Pérez-Sánchez N; Andreu I; García-Moral A; Agúndez JA; Bartra J; Doña I; Torres MJ; Blanca M; Blanca-López N; Canto G
J Investig Allergol Clin Immunol; 2017; 27(1):32-39. PubMed ID: 28211343
[TBL] [Abstract][Full Text] [Related]
53. Intolerance to nonsteroidal antiinflammatory drugs: results of controlled drug challenges in 98 patients.
Quiralte J; Blanco C; Castillo R; Delgado J; Carrillo T
J Allergy Clin Immunol; 1996 Sep; 98(3):678-85. PubMed ID: 8828546
[TBL] [Abstract][Full Text] [Related]
54. Different Phenotypes of Non-Steroidal Anti-Inflammatory Drug Hypersensitivity during Childhood.
Cavkaytar O; Arik Yilmaz E; Karaatmaca B; Buyuktiryaki B; Sackesen C; Sekerel BE; Soyer O
Int Arch Allergy Immunol; 2015; 167(3):211-21. PubMed ID: 26315297
[TBL] [Abstract][Full Text] [Related]
55. Results of NSAID provocation tests and difficulties in the classification of children with nonsteroidal anti-inflammatory drug hypersensitivity.
Yilmaz Topal O; Kulhas Celik I; Turgay Yagmur I; Toyran M; Civelek E; Karaatmaca B; Kocabas CN; Dibek Misirlioglu E
Ann Allergy Asthma Immunol; 2020 Aug; 125(2):202-207. PubMed ID: 32294526
[TBL] [Abstract][Full Text] [Related]
56. Genetic variants of the arachidonic acid pathway in non-steroidal anti-inflammatory drug-induced acute urticaria.
Cornejo-García JA; Jagemann LR; Blanca-López N; Doña I; Flores C; Guéant-Rodríguez RM; Torres MJ; Fernández J; Laguna JJ; Rosado A; Agúndez JA; García-Martín E; Canto G; Guéant JL; Blanca M
Clin Exp Allergy; 2012 Dec; 42(12):1772-81. PubMed ID: 23181793
[TBL] [Abstract][Full Text] [Related]
57. Safety of cyclooxygenase 2 inhibitors and increased leukotriene synthesis in chronic idiopathic urticaria with sensitivity to nonsteroidal anti-inflammatory drugs.
Zembowicz A; Mastalerz L; Setkowicz M; Radziszewski W; Szczeklik A
Arch Dermatol; 2003 Dec; 139(12):1577-82. PubMed ID: 14676074
[TBL] [Abstract][Full Text] [Related]
58. Safety of etoricoxib, a new cyclooxygenase 2 inhibitor, in patients with nonsteroidal anti-inflammatory drug-induced urticaria and angioedema.
Sánchez-Borges M; Caballero-Fonseca F; Capriles-Hulett A
Ann Allergy Asthma Immunol; 2005 Aug; 95(2):154-8. PubMed ID: 16136765
[TBL] [Abstract][Full Text] [Related]
59. [Clinical findings of sensitivity to analgesics and nonsteroidal antiinflammatory drugs].
Rosário NA; Ribeiro AC
Rev Assoc Med Bras (1992); 2000; 46(3):201-6. PubMed ID: 11070509
[TBL] [Abstract][Full Text] [Related]
60. Avoidance of nonsteroidal anti-inflammatory drugs after negative provocation tests in urticaria/angioedema reactions: Real-world experience.
Bommarito L; Zisa G; Riccobono F; Villa E; D'Antonio C; Calamari AM; Poppa M; Moschella A; Di Pietrantonj C; Galimberti M
Allergy Asthma Proc; 2014; 35(4):303-6. PubMed ID: 24992549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
